Xenetic biosciences, inc. (XBIO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Nov'13Aug'13Jun'13May'13Mar'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11
Revenue
Collaboration services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

56

-

-

-

0

-

-

-

-

-

85

-

-

-

0

-

-

-

-

-

-

-

-

-

0

2

-8

1,000

39

0

32

32

26

36

35

13

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

1,000

29

0

-

-

-

36

-

-

Operating costs and expenses:
Cost of research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

39,500

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of research and development revenue

-

-

-

-

-

-

-

-

-

-

97

59

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

-

-

-

-

-

-

Cost of research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

9

-

-

-

-

0

-

-

Research and development

359

417

3,520

487

463

514

735

927

706

1,080

884

873

1,221

40,211

891

2,205

429

1,026

816

555

1,035

2,821

1,905

1,032

564

-

-

956

-

622

-

-

-

-

-

-

General and administrative

927

834

2,142

890

863

1,124

1,079

1,066

1,122

1,988

1,343

1,970

1,634

2,352

1,359

1,557

1,422

1,664

2,984

803

935

1,396

1,203

1,607

2,394

-

-

1,075

-

764

-

-

-

-

-

-

Goodwill impairment

-

-

3,283

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Aircraft maintenance and fee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-2

12

6

15

10

3

Fuel and oil

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-3

11

7

9

8

1

Management fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

7

-

-

-

-

Management fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-2

-

-

6

6

2

Officer compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

-

-

-

-

0

-

-

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

30

-

23

-

17

7

43

34

30

17

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

-

-

-

-

-

5

-

-

-

-

Administrative fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

5

-

-

5

5

3

Administrative fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-

0

-

-

0

0

0

Total operating costs and expenses

1,287

-

-

-

1,327

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,959

78

64

2,032

39

1,386

14

44

66

72

62

28

Loss from operations

-1,230

-1,234

-8,946

-1,378

-1,327

-1,639

-1,814

-1,993

-1,828

4,430

-2,240

-2,903

-2,855

-64

-2,251

-43,262

-1,851

-2,691

-3,800

-1,359

-1,970

-4,217

-3,108

-2,639

-2,959

-76

-62

-1,032

-10

-1,386

18

-11

-40

-35

-26

-14

Other income (expense):
Change in fair value of derviative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-21

241

1,769

136

-780

-1,344

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of hybrid debt instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-106

0

-1,584

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of hybrid debt instrument

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on conversion of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-6,187

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-1,069

-

-

0

-

-

-

-

-

-

-

-

Other expense

-0

3

-0

0

-0

0

2

-32

5

8

-14

-25

-9

-58

-13

12

-26

-

-50

234

-

-91

-72

-128

-34

-

-

85

-

10

-

-

-

-

-

-

Interest income, net

51

61

46

0

0

0

0

-0

0

-

-0

9

-0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

459

-

-

-

-

-5

-13

-

-3

-

-3

-3

-3

-3

-3

-3

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

39

341

103

245

136

127

1

1

-

-

1

0

-5

-3

0

-3

-

-3

-3

-3

-3

-3

-3

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

10

1

-

-

9

-

10

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense)

51

64

46

0

-0

0

2

-32

5

14

-15

-15

-9

-326

-220

-4,508

-1,719

-935

-1,522

233

-460

-85

-73

-118

-1,103

-

-

94

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,758

-4,063

-

-

-938

-

-1,375

-

-

-

-

-

-

Income tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

-

0

-

-

-

-

-

-

Net loss

-1,179

-1,170

-8,900

-1,377

-1,327

-1,639

-1,812

-2,026

-1,822

4,445

-2,255

-2,918

-2,865

-391

-2,471

-47,771

-3,571

-3,627

-5,323

-1,125

-2,431

-4,302

-3,182

-2,758

-4,063

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend

0

0

1,404

0

3,879

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common stockholders

-1,179

-1,170

-10,305

-1,377

-5,206

-1,639

-1,812

-2,026

-1,822

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-938

-

-1,375

-

-

-

-

-

-

Other comprehensive loss from foreign currency translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

5

-338

11

-306

-542

397

125

-

-

8

-

-1,220

-

-

-

-

-

-

Total comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,627

-5,318

-1,464

-2,419

-4,609

-3,724

-2,361

-3,937

-

-

-929

-

-2,595

-

-

-

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-82

-76

-

-13

-

15

-14

-43

-38

-29

-18

Basic and diluted loss per share

-0.19

4.35

-2.67

-1.56

-6.45

-4.36

-2.31

-2.78

-0.21

0.53

-0.26

-0.34

-0.34

-0.66

-0.28

-6.12

-0.78

-

-1.26

-0.27

-

-0.04

-0.02

-0.02

-0.03

0.00

0.00

-0.01

0.00

-0.01

0.00

-0.00

-0.01

0.00

0.00

0.00

Weighted-average shares of common stock outstanding, basic and diluted

6,233

5,857

3,862

882

806

-7,206

783

728

8,717

8,720

8,717

8,706

8,518

8,339

8,987

7,804

4,591

-

4,228

4,221

-

135,426

136,052

136,052

136,052

-

-

119,831

-

119,831

-

-

-

-

-

-

Weighted average shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

135,000

256,500

-

135,000

-

135,000

13,500

345,307

121,304

100,000

10,000

Royalty [Member]
Total revenues

56

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-